1. Home
  2. NTZ vs KYNB Comparison

NTZ vs KYNB Comparison

Compare NTZ & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

N/A

Current Price

$3.00

Market Cap

34.3M

ML Signal

N/A

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$7.09

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTZ
KYNB
Founded
1959
1993
Country
Italy
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
31.9M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
NTZ
KYNB
Price
$3.00
$7.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.5K
8.1K
Earning Date
04-13-2023
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.15
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$6.32
52 Week High
$4.46
$9.58

Technical Indicators

Market Signals
Indicator
NTZ
KYNB
Relative Strength Index (RSI) 49.46 48.94
Support Level $2.59 $7.04
Resistance Level $3.17 $7.50
Average True Range (ATR) 0.20 0.20
MACD -0.01 0.00
Stochastic Oscillator 71.98 30.23

Price Performance

Historical Comparison
NTZ
KYNB

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: